Rivastigmine Tartrate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 71209-014
  • Package NDC 71209-014-03
  • Package NDC 71209-014-10
  • Application number ANDA203844
  • SPL ID 862f0b42-695e-4170-983d-cfb848967cf3
  • SPL set ID e7e641fe-39bd-4681-a430-6dedeb6d6af5
  • UNII 9IY2357JPE
  • RxCUI 312835
  • RxCUI 312836
  • RxCUI 314214
  • RxCUI 314215

What the source publishes

Labeler
Cadila Pharmaceuticals Limited
Active ingredients
Rivastigmine Tartrate
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:71209-014_862f0b42-695e-4170-983d-cfb848967cf3
{
  "name": "Rivastigmine Tartrate",
  "splId": "862f0b42-695e-4170-983d-cfb848967cf3",
  "labels": [
    {
      "setId": "e7e641fe-39bd-4681-a430-6dedeb6d6af5",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e7e641fe-39bd-4681-a430-6dedeb6d6af5",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e7e641fe-39bd-4681-a430-6dedeb6d6af5"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Cadila Pharmaceuticals Limited",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "60 CAPSULE in 1 BOTTLE (71209-014-03)",
      "package_ndc": "71209-014-03",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20140211"
    },
    {
      "sample": false,
      "description": "500 CAPSULE in 1 BOTTLE (71209-014-10)",
      "package_ndc": "71209-014-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20140211"
    }
  ],
  "productId": "71209-014_862f0b42-695e-4170-983d-cfb848967cf3",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "71209-014",
  "deaSchedule": null,
  "genericName": "Rivastigmine Tartrate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "RIVASTIGMINE TARTRATE",
      "strength": "4.5 mg/1"
    }
  ],
  "applicationNumber": "ANDA203844",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20140211",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0371209012034",
      "0371209014038",
      "0371209013031"
    ],
    "unii": [
      "9IY2357JPE"
    ],
    "rxcui": [
      "312835",
      "312836",
      "314214",
      "314215"
    ],
    "spl_set_id": [
      "e7e641fe-39bd-4681-a430-6dedeb6d6af5"
    ],
    "manufacturer_name": [
      "Cadila Pharmaceuticals Limited"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:71209-014_862f0b42-695e-4170-983d-cfb848967cf3"